Quantcast

Latest metastatic melanoma Stories

2010-06-07 08:00:00

SAN DIEGO, June 7 /PRNewswire/ -- Physicians attending the annual meeting of the American Society of Clinical Oncology (ASCO) presented evidence that pegylated arginine deiminase (ADI-PEG 20), a novel anticancer drug that targets ASS(-) tumors, and which is being developed and manufactured by Polaris Group, was effective in inhibiting the growth of metastatic melanoma cells.

2010-06-07 05:00:00

KNOXVILLE, Tenn., June 7 /PRNewswire-FirstCall/ -- Provectus Pharmaceuticals, Inc.

2010-05-12 07:58:00

INDIANAPOLIS, May 12 /PRNewswire-FirstCall/ -- Data from several Lilly Oncology compounds in development - a total of 13 studies - will be presented during the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO) held in Chicago, Ill. from June 4 - 8, 2010.

2009-08-11 09:56:00

KNOXVILLE, Tenn., Aug. 11 /PRNewswire-FirstCall/ -- Provectus Pharmaceuticals, Inc.

2009-07-29 15:15:16

U.S. researchers say dendritic cell vaccines may lead to long-term survival for metastatic melanoma patients, the most serious form of skin cancer.

2009-07-28 14:57:00

NEWPORT BEACH, Calif., July 28 /PRNewswire/ -- Hoag Memorial Hospital Presbyterian today announced promising data from a clinical study showing patient-specific cancer vaccines derived from patients' own cancer cells and immune cells were well tolerated and resulted in impressive long-term survival rates in patients with metastatic melanoma whose disease had been minimized by other therapies.

2009-07-28 15:12:36

Hoag Memorial Hospital Presbyterian today announced promising data from a clinical study showing patient-specific cancer vaccines derived from patients' own cancer cells and immune cells were well tolerated and resulted in impressive long-term survival rates in patients with metastatic melanoma whose disease had been minimized by other therapies.

2009-06-01 07:00:00

Objective Response of Treated Lesions Observed in 60% of Subjects KNOXVILLE, Tenn., June 1 /PRNewswire-FirstCall/ -- Provectus Pharmaceuticals, Inc.

2009-05-15 11:28:00

WOBURN, Mass., May 15 /PRNewswire/ -- BioVex Inc, a company developing new generation biologics for the treatment and prevention of cancer and infectious disease, announced today that updated survival data from its Phase II study in metastatic melanoma will be presented at the 2009 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place from May 29, 2009 - June 2, 2009 in Orlando, FL.


Word of the Day
whirret
  • To give a box on the ear to.
The word 'whirret' may be onomatopoeic.